Instructions for use of Pfizer’s new drug talazoparib (Talzenna)

Talazoparib (trade nameTalzenna), developed by Pfizer, is a cutting-edge PARP inhibitor that has demonstrated significant clinical effects in the treatment of breast cancer and prostate cancer. To ensure that patients can use this medication safely and effectively, the following are guidelines for the use of talazoparib.

1. Dosage and administration method

The dosage and administration of talazoparib must strictly follow your doctor's instructions. For breast cancer patients, it is usually recommended to take it orally once a day, and the dosage depends on the prescription, generally 1 mg. Patients with prostate cancer need to use it in combination with enzalutamide, and the dosage must also follow the doctor's advice. It is generally recommended to take 0.5 mg orally daily. Patients should try to take the medicine at the same time every day to maintain a stable concentration of the medicine in the body.

2. Medication time

Choosing a fixed administration time, such as morning or evening, can help maintain stable distribution and sustained effects of the drug in the body. Patients should avoid missing doses or changing medication times at will.

3. Precautions

1. During the period of using talazoparib, patients should regularly monitor blood routine, liver and kidney function and other indicators to evaluate the impact of the drug on the body.

2. If common adverse reactions such as nausea, vomiting, fatigue, etc. occur, the doctor should be informed in time so that the treatment plan can be adjusted.

3. This drug is prohibited for those who are allergic to talazoparib. Pregnant and lactating women should use it with caution under the guidance of a doctor. If you have any pregnancy or lactation plans, be sure to inform your doctor in advance.

4. Drug Storage

Talazoparib should be stored in a cool, dry, ventilated place, away from direct sunlight and high temperatures. Please keep medicines out of the reach of children to avoid accidental ingestion.

In short, talazoparib is an important anti-tumor drug, and its correct use is crucial to ensure efficacy and reduce side effects. Patients should strictly follow the doctor's instructions, take the medicine on time and in the right amount, and pay attention to the effects of the medicine on the body. If you have any questions or discomfort, please seek medical advice in time. In addition, there are different strengths and versions of talazoparib on the market, and patients should choose the appropriate drug based on their own needs and treatment options.